We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Appeals Court Upholds Allergan Eye Drug Zymar Patent Invalidation
Appeals Court Upholds Allergan Eye Drug Zymar Patent Invalidation
A federal appeals court has affirmed a lower court ruling that Allergan’s Zymar eye drop patent is invalid because the process is obvious for others to try.